Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition.

Atasoy S, Vohryzek J, Deco G, Carhart-Harris RL, Kringelbach ML.

Prog Brain Res. 2018;242:97-120. doi: 10.1016/bs.pbr.2018.08.009. Epub 2018 Oct 25.

PMID:
30471684
2.

Predicting Responses to Psychedelics: A Prospective Study.

Haijen ECHM, Kaelen M, Roseman L, Timmermann C, Kettner H, Russ S, Nutt D, Daws RE, Hampshire ADG, Lorenz R, Carhart-Harris RL.

Front Pharmacol. 2018 Nov 2;9:897. doi: 10.3389/fphar.2018.00897. eCollection 2018.

3.

How do psychedelics work?

Carhart-Harris RL.

Curr Opin Psychiatry. 2019 Jan;32(1):16-21. doi: 10.1097/YCO.0000000000000467.

PMID:
30394903
4.

More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression.

Lyons T, Carhart-Harris RL.

Front Psychol. 2018 Oct 12;9:1721. doi: 10.3389/fpsyg.2018.01721. eCollection 2018.

5.

Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD.

Deco G, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris RL, Whybrow PC, Logothetis NK, Kringelbach ML.

Curr Biol. 2018 Oct 8;28(19):3065-3074.e6. doi: 10.1016/j.cub.2018.07.083. Epub 2018 Sep 27.

PMID:
30270185
6.

Psychedelics, Meditation, and Self-Consciousness.

Millière R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A.

Front Psychol. 2018 Sep 4;9:1475. doi: 10.3389/fpsyg.2018.01475. eCollection 2018.

7.

Serotonin, psychedelics and psychiatry.

Carhart-Harris RL.

World Psychiatry. 2018 Oct;17(3):358-359. doi: 10.1002/wps.20555. No abstract available.

8.

DMT Models the Near-Death Experience.

Timmermann C, Roseman L, Williams L, Erritzoe D, Martial C, Cassol H, Laureys S, Nutt D, Carhart-Harris R.

Front Psychol. 2018 Aug 15;9:1424. doi: 10.3389/fpsyg.2018.01424. eCollection 2018.

9.

Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.

Gabay AS, Carhart-Harris RL, Mazibuko N, Kempton MJ, Morrison PD, Nutt DJ, Mehta MA.

Sci Rep. 2018 May 29;8(1):8236. doi: 10.1038/s41598-018-26656-2.

10.

Correction to: The hidden therapist: evidence for a central role of music in psychedelic therapy.

Kaelen M, Giribaldi B, Raine J, Evans L, Timmermann C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R.

Psychopharmacology (Berl). 2018 May;235(5):1623. doi: 10.1007/s00213-018-4886-8.

11.

The entropic brain - revisited.

Carhart-Harris RL.

Neuropharmacology. 2018 Nov;142:167-178. doi: 10.1016/j.neuropharm.2018.03.010. Epub 2018 Mar 14. Review.

PMID:
29548884
12.

Psychedelics and the essential importance of context.

Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, Kaelen M.

J Psychopharmacol. 2018 Jul;32(7):725-731. doi: 10.1177/0269881118754710. Epub 2018 Feb 15.

PMID:
29446697
13.

Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.

Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL.

J Affect Disord. 2018 Apr 1;230:84-86. doi: 10.1016/j.jad.2018.01.006.

PMID:
29407543
14.

The hidden therapist: evidence for a central role of music in psychedelic therapy.

Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R.

Psychopharmacology (Berl). 2018 Feb;235(2):505-519. doi: 10.1007/s00213-017-4820-5. Epub 2018 Feb 2. Erratum in: Psychopharmacology (Berl). 2018 Mar 26;:.

15.

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.

Roseman L, Nutt DJ, Carhart-Harris RL.

Front Pharmacol. 2018 Jan 17;8:974. doi: 10.3389/fphar.2017.00974. eCollection 2017.

16.

Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.

Lyons T, Carhart-Harris RL.

J Psychopharmacol. 2018 Jul;32(7):811-819. doi: 10.1177/0269881117748902. Epub 2018 Jan 17.

17.

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.

Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL.

Neuropharmacology. 2018 Nov;142:263-269. doi: 10.1016/j.neuropharm.2017.12.041. Epub 2017 Dec 27.

18.

Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD.

Atasoy S, Roseman L, Kaelen M, Kringelbach ML, Deco G, Carhart-Harris RL.

Sci Rep. 2017 Dec 15;7(1):17661. doi: 10.1038/s41598-017-17546-0.

19.

LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm.

Timmermann C, Spriggs MJ, Kaelen M, Leech R, Nutt DJ, Moran RJ, Carhart-Harris RL, Muthukumaraswamy SD.

Neuropharmacology. 2018 Nov;142:251-262. doi: 10.1016/j.neuropharm.2017.10.039. Epub 2017 Nov 20.

PMID:
29101022
20.

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.

Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ.

Sci Rep. 2017 Oct 13;7(1):13187. doi: 10.1038/s41598-017-13282-7.

Supplemental Content

Loading ...
Support Center